Skip to main content
Premium Trial:

Request an Annual Quote

Two Cents

The re-opened comment period for feedback to the US Food and Drug Administration on direct-to-consumer genetic testing ends today. The panel focused on molecular and clinical genetics, which is part of the medical devices committee, is seeking “input and comments from interested stakeholders to discuss scientific issues concerning DTC tests,” according to the Federal Register. At Genomes Unzipped, Luke Jostins urges his readers to share their thoughts with FDA. "The FDA needs to hear the full diversity of opinions and facts on this subject to make an informed decision," he writes. An older blog post from Dan Vorhaus at the Genomic Law Report adds that FDA will be following this comment period with town hall-style meetings, including one this week in Orlando, Fla.

HT: Razib Khan at Gene Expression

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.